AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05596084 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: maxillary sinus augmentation and implant placement
Description: For maxillary sinus augmentation, the area will be prepared by lifting a full-thickness flap. The sinus membrane will be carefully elevated by opening a window through the lateral wall of the sinus on both sides.platelet-rich fibrin prepared with titanium on the other side will be placed in the space prepared in the sinus region by random selection. For Platelet-rich fibrin prepared with titanium (T-PRF), the blood taken from the patient to a 20 cc injektor was put into titanium tubes and prepared by centrifugation at 2700 rpm for 14 minutes according to the standard protocol. Then, 6 months after the surgery, histological sample will be taken with a trephine bur in both groups and the implant will be placed in accordance with the standard protocol. The stability value (ISQ) of the placed implant will be measured with the Ostell device at the time the implant is placed and 3 months after it is placed.
Study NCT05596084 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Maxillary sinus augmentation with bovine bone graft
Description: For maxillary sinus augmentation, the area will be prepared by lifting a full-thickness flap. The sinus membrane will be carefully elevated by opening a window through the lateral wall of the sinus on both sides. Bio-oss bovine bone graft on one side will be placed in the space prepared in the sinus region by random selection. For Platelet-rich fibrin prepared, the blood taken from the patient to a 20 cc injektor was put into titanium tubes and prepared by centrifugation at 2700 rpm for 13 minutes according to the standard protocol. Then, 6 months after the surgery, histological sample will be taken with a trephine bur in both groups and the implant will be placed in accordance with the standard protocol. The stability value (ISQ) of the placed implant will be measured with the Ostell device at the time the implant is placed and 3 months after it is placed.
Study NCT05445154 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKLB1028 Dose Escalation
Description: Drug :SKLB1028 ;Drug: Cytarabine ;Drug: Daunorubicin
Study NCT05067439 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Abrocitinib
Description: 200 mg once daily (QD)
Study NCT05067439 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Omeprazole
Description: single doses of 10 mg
Study NCT05067439 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Caffeine
Description: single dose of 100 mg
Study NCT05067439 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Efavirenz
Description: single doses of 50 mg
Study NCT06373484 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Parent Training
Description: Two 15-session multi-component cognitive-behavioral group treatments for children with disruptive behavior and their parents (i.e., one program for children aged 6-8 years and their parents and another for children aged 9-12 years and their parents. The programs have a child and parent group that are implemented concurrently).
Study NCT06228521 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Liquid nitrogen sprayed
Description: Liquid nitrogen sprayed on each wart using a standardised technique. Freeze-thaw cycle repeated up to 3 times per wart per session. 4 sessions at weekly intervals.
Study NCT06228521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 980nm diode laser applied
Description: 980nm diode laser applied to each wart for 5 seconds at 2W power and 1mm spot size. 4 sessions at weekly intervals.
Study NCT06267456 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Upper Limb Rotation Test
Description: The athlete is positioned with the shoulder, elbow lateral epicondyle, greater trochanter, and ankle lateral malleolus in contact with the wall. In the push-up position, the elbows are started at shoulder height with a 90° bend, and the feet are placed in a shoulder-width apart position. Athletes are instructed to perform a rotation of the shoulder and trunk by touching a vertically placed band on the wall for 15 seconds in the position of 90° abduction and 90° external rotation of the shoulder. The tested side is the upper extremity where the closed kinetic chain position is maintained.
Study NCT05433311 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercises
Description: Neutral position training, transversus abdominis/multifidius/abdominal/back extensors strengthening exercise, bridge exercise, cat-camel exercise, lumbal extensor/hamstring/gastrosoleus/latissimus dorsi/gluteal stretching exercises
Study NCT06052345 — intervention group
Intervention type: DEVICE
Intervention: Garmin smartwatch
Description: * Physical activity (Activity sessions, type and length of activity, activity intensity estimations)~* Meal detection and meal characteristics (accelerometry and gyroscope data)~* Oxygen saturation (pulse oximetry)~* Number of steps (pedometer)~* Stress level indicators (based on heart-rate analytics)~* Sleep patterns (sleep and wake-up time, sleep quality)
Study NCT06052345 — intervention group
Intervention type: OTHER
Intervention: REBECCA Mobile application
Description: * GPS positioning (daily location change patterns through pathway analysis and Point-of-interest analysis based on type-of-location automatic detection)~* Self-reports from patients and companions reports on mental and physical health, as well as periodic quality of life evaluations3~* Patient self-uploaded pictures of meals (for evaluation of nutritional habits) and living environment stressors (for evaluation of living environment and self-perceived stressor analysis)
Study NCT06052345 — intervention group
Intervention type: OTHER
Intervention: REBECCA PC plug-in
Description: * the developed plug-in monitors online activity, collecting anonymized data from web-browsers (Chrome) and social media (Facebook, Youtube and Instagram).~* These are relevant to current and historical data on: i) keywords in searches, ii) types of websites visited, iii) reactions to posts, iv) participation in online groups, v) types of bookmarked websites
Study NCT05139602 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subcutaneous Injection
Study NCT05204927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-I&T
Description: Radioligand therapy
Study NCT05204927 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Abiraterone with Prednisone or Enzalutamide
Description: Hormone Therapy
Study NCT05382091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: naltrexone implant
Description: 3.6 g per implant set each containing 60% naltrexone
Study NCT04349059 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Animal based diet
Description: Food will be provided by Montefiore-Einstein Food Services
Study NCT04349059 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Plant based diet
Description: Food will be provided by Montefiore-Einstein Food Services
Study NCT05474170 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AHA resuscitation sequence
Description: Starting the cardiopulmonary resuscitation by following the AHA guideline, meaning starting with 15 chest compressions, followed by 2 ventilations
Study NCT05474170 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: AHA resuscitation sequence
Description: Starting the cardiopulmonary resuscitation by following the AHA guideline, meaning starting with 15 chest compressions, followed by 2 ventilations
Study NCT05474170 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ERC resuscitation sequence
Description: Starting the cardiopulmonary resuscitation by following the ERC guideline, meaning starting with 5 initial ventilations, then alternating 15 chest compressions with 2 ventilations
Study NCT05474170 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ERC resuscitation sequence
Description: Starting the cardiopulmonary resuscitation by following the ERC guideline, meaning starting with 5 initial ventilations, then alternating 15 chest compressions with 2 ventilations
Study NCT05274854 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: a)standardised dietician supervised intervention, b) exercise intervention, c) internet delivered cognitive behavior therapy or d) nothing
Description: Pre consultation interventions consist of one of four intervention a)standardised dietician supervised intervention, b) exercise intervention, c) internet delivered cognitive behavior therapy or d) nothing
Study NCT05274854 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: a) consultant-led outpatient clinic or b) a integrated care clinic
Description: Consultation intervention consists of one of two interventions a) consultant-led outpatient clinic or b) a integrated care clinic
Study NCT06648200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS004
Description: Specified dose on specified days.
Study NCT06648200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Toripalimab
Description: Specified dose on specified days.
Study NCT06648200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Specified dose on specified days.
Study NCT06648200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etoposide
Description: Specified dose on specified days.
Study NCT06648200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Specified dose on specified days.
Study NCT06648200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Platinum
Description: Specified dose on specified days.
Study NCT06648200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum
Description: Specified dose on specified days.
Study NCT04893447 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SPI+
Description: Suicide prevention hotline follow-up specialists will call participants to (1) conduct a brief suicide risk assessment; (2) review and discuss the participant's connection and support plan or safety plan; and (3) provide referrals to social services or other support with treatment engagement, if indicated. Participants will receive at least one and optional additional phone calls, generally delivered according to the following schedule: days 3, 7, 14, 30, 60, 90. Modifications may be made to the schedule due to weekends, holidays, or participant availability, and additional calls may be scheduled as desired by the participant. The follow-up will stop once the participant is successfully engaged in outpatient treatment or does not desire further follow-up support.
Study NCT04893447 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SP+CC (Caring Contacts)
Description: SP+CC follow-up includes one phone conversation with a suicide prevention hotline follow-up specialist and a series of personalized caring messages sent over the course of 12 months via text or email (based on participant preference). Caring contacts will generally be sent according to the following schedule: 3 in the first week, 6 weekly, 6 bi-weekly, 4 monthly; 2 bi-monthly, and one each for the participant's birthday, Thanksgiving, Christmas, and New Year's (total of 25 over 12 months). Slight variation in the schedule is allowed. There is no expectation that participants respond to the text messages; if they do, follow-up specialists reply to any incoming texts. Replies are individually-tailored and caring.
Study NCT06289478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid administration
Description: Tranexamic acid will be topically administered in intervention groups
Study NCT06289478 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Topical tranexamic acid administration
Description: Tranexamic acid will be topically administered in intervention groups
Study NCT06288360 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: 200 mg, intravenously, 20-60 min. 2 times, every 21 days
Study NCT06288360 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel-albumin
Description: 260 mg/m² over 30 min, 3 times, every 21 days
Study NCT06288360 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 4 h, 75-80 mg/m², 3 times, every 21 days
Study NCT06288360 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: radical surgery
Description: Radical hysterectomy + pelvic lymphadenectomy 士 para-aortic lymphadenectomy
Study NCT06070181 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Enamel matrix derivate
Description: 'Applying Enamel matrix derivate in the periodontal pockets after completing the non-surgical periodontal treatment
Study NCT06070181 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Non-surgical periodontal treatment
Description: No additional/adjunctive treatment with Emdogain
Study NCT06070181 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment
Description: No additional/adjunctive treatment with Emdogain
Study NCT05406115 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMG 786
Description: Oral tablet
Study NCT05406115 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral tablet
Study NCT05066204 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sequence of teaching-/learningmethod
Description: see: arm/group descriptions
Study NCT06267456 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Closed Kinetic Chain Upper Extremity Stability Test
Description: Athletes were placed in a push-up position with a distance of 91.44 centimeters (cm) (3 feet) between their hands for the test position. Subsequently, they were instructed to touch one hand to the other as quickly as possible. The total number of touches within a 15-second period was recorded. Modified push-up position was used for women, and regular push-up position for men during this time. Prior to the test, a familiarization trial consisting of 5 repetitions was performed. The test was then repeated 3 times, and the average of these repetitions was recorded as the score. Individuals were given a 45-second rest period between repetitions. The normalized score, representing the touch count per individual's height, was calculated. The power score was obtained by multiplying the touch count by 68% of the individual's body weight in kilograms.
Study NCT06267456 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Upper Quarter Y Balance Test
Description: The Upper Extremity Y Balance Test was created using three rulers placed on the ground in the medial, inferolateral, and superolateral directions. The rulers in the superolateral and inferolateral directions were positioned at a 90° angle to each other, while the ruler in the medial direction was placed at a 135° angle with respect to these two directions. In this test, both arms started in a push-up position with shoulder-width apart. The athlete was then instructed to touch, using their non-dominant hand, the maximum reachable point in the medial, inferolateral, and superolateral directions.
Study NCT06274879 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabin, Cisplatin and Durvalumab
Description: CICI (Gemcitabin d1 \& d8 Cisplatin d1 \& d8, Durvalumab d1) are administered repeating every 21 days for a total of 8 cycles.
Study NCT06274879 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabin, Cisplatin and Durvalumab
Description: CICI (Gemcitabin d1 \& d8 Cisplatin d1 \& d8, Durvalumab d1) are administered repeating every 21 days for a total of 8 cycles.
Study NCT06274879 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biliary Radiofrequency Ablation
Description: Biliary Radiofrequency Ablation is applied at baseline, 6 and 12 weeks
Study NCT06274879 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Retrograde Cholangio-Pancreatography with stenting
Description: ERCP with stenting are applied at baseline and as clinically indicated
Study NCT06274879 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic Retrograde Cholangio-Pancreatography with stenting
Description: ERCP with stenting are applied at baseline and as clinically indicated
Study NCT06496191 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FMT
Description: - Single dose (30gm/90ml) of FMT will be given via upper GI gastroduodenoscope at D4
Study NCT06496191 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SMT
Description: Baclofen + AUD counselling
Study NCT06496191 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SMT
Description: Baclofen + AUD counselling
Study NCT06496191 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo identical to the FMT arm.
Study NCT05628805 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: iTBS
Description: intermittent theta burst stimulation with TMS
Study NCT05628805 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iTBS
Description: intermittent theta burst stimulation with TMS
Study NCT04719039 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Restorative Yoga Internvention
Description: Participants in the intervention group will receive links to two 60-min videos per week for 8 consecutive weeks. Each video will include a yoga practice guided by a certified yoga instructor. The intervention group is required to perform the yoga practice at least two times per week. If preferred, they can do additional sessions with the videos and record their total hours of self-practice.
Study NCT05581680 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: dental impressions
Description: dental impressions
Study NCT05581680 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dental impressions
Description: dental impressions
Study NCT05581680 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Simultaneous MoCap and EMG acquisition
Description: Simultaneous MoCap and EMG acquisition
Study NCT05581680 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simultaneous MoCap and EMG acquisition
Description: Simultaneous MoCap and EMG acquisition
Study NCT05581680 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Eye-tracking acquisition for pathological subjects
Description: Eye-tracking acquisition for pathological subjects
Study NCT05581680 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Follow-up visit for pathological subjects
Description: Follow-up visit for pathological subjects
Study NCT04595097 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: inspiratory muscle traiing
Description: The patients are encouraged to inhale against a load to increase the inspiratory muscle strength and endurance
Study NCT04595097 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: inspiratory muscle traiing
Description: The patients are encouraged to inhale against a load to increase the inspiratory muscle strength and endurance
Study NCT05065164 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab Only Product
Description: denosumab subcutaneous injection /6 months, twice a year
Study NCT05065164 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Denosumab Only Product
Description: denosumab subcutaneous injection /6 months, twice a year
Study NCT06491654 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise
Description: During the study period (1 week for acute effects, 12 weeks for chronic effects), there will be 8 sessions per month, lasting 40-60 minutes each, with 2 sessions per week on alternate days, totaling 24 sessions. Each session includes: (1) warm-up (mobility exercises); (2) training: 5-min warm-up, followed by 15-min moderate-to-high intensity circuit of 7 functional global exercises with 10 reps each at a perceived exertion effort (RPE) of 5-7 on a scale of 1 to 10; (3) Aerobic exercise: starting at 15 mins, increasing by 5 mins biweekly to 30 mins by week 7; (4) Cool-down (general mobility); (5) Application of cohesive compressive bandage on the affected upper limb, worn for 2 hours post-session, removed at home. Participants may add a cotton bandage and finger bandage if needed.
Study NCT05108298 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaires
Description: Patients will complete questionnaires online through EASEE-PRO. There will be a set of fixed questionnaires at each timepoint for both arms. The patients will be asked to rank the 15 types of PROs according to their importance. The participants randomized to the choice arm will be asked to choose 5 of the 15 PROs to complete. The participants randomized to the fixed arm will be given a fixed 5 of the 15 PROs at each time point.
Study NCT05375383 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Streptococcus salivarius K12 lozenge
Description: In this study, a lozenge will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
Study NCT05375383 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius K12 lozenges containing prebiotic A
Description: In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
Study NCT05108298 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Patients will complete questionnaires online through EASEE-PRO. There will be a set of fixed questionnaires at each timepoint for both arms. The patients will be asked to rank the 15 types of PROs according to their importance. The participants randomized to the choice arm will be asked to choose 5 of the 15 PROs to complete. The participants randomized to the fixed arm will be given a fixed 5 of the 15 PROs at each time point.